Key result
Preoperative factors including platelet count < 135,000 (OR 2.04), INR > 1.2 (OR 1.87), and need for dialysis (OR 5.69) were significantly associated with increased 30-day mortality after surgical evacuation of subdural hematomas.
Why the study?
The rate of postoperative morbidity and mortality after subdural hematoma evacuation is high, and significant preoperative predictors of mortality and length of stay need to be determined.
Cohort (n=2,709)
Yes
Odds Ratio: 2.04 (95% CI 1.39–2.99)
Absolute Event Rate: 32.1% vs 14.4%
p-value: p=<0.001
Specific laboratory abnormalities, even at levels generally considered normal, and chronic conditions are significant preoperative predictors of 30-day mortality in patients undergoing operative evacuation of subdural hematomas.
These preoperative markers may aid risk stratification before subdural hematoma evacuation; hypothesis-generating and requires prospective validation before practice change.
The rate of postoperative morbidity and mortality after subdural hematoma (SDH) evacuation is high. The aim of this study was to compare mortality statistics from a high-volume database to historical figures and determine the most significant preoperative predictors of mortality and length of stay (LOS). The National Surgical Quality Improvement Program registry was searched (2005-2016) for patients with operatively treated SDHs, of which 2709 were identified for univariate analysis. After exclusion for missing data, 2010 individuals were analyzed with multivariable logistic regression. Primary outcome was 30-day mortality. The average patient age was 68.8 ± 14.9 years, and 64.1% were males. Upon multivariate analysis, nine variables were found to be associated with increased mortality: platelet count < 135,000 (OR 2.04, 95% CI 1.39-2.99), INR >1.2 (OR 1.87, 95% CI 1.34-2.6), bleeding disorder (OR 1.80, 95% CI 1.32-2.46), need for dialysis within two weeks preoperatively (OR 5.69, 95% CI 3.15-10.27), ventilator dependence in the 48 hours preceding surgery (OR 3.99, 95% CI 2.82-5.63), disseminated cancer (OR 2.95, 95% CI 1.34-6.47), WBC count >10,000 (OR 1.55, 95% CI 1.15-2.08), totally dependent functional status (OR 1.84, 95% CI 1.2-2.8), and each increasing year of age (OR 1.04, 95% CI 1.031-1.05). It is not surprising that chronic conditions and functional status were associated with increased mortality. However, specific laboratory abnormalities were also associated with increased mortality at levels generally considered within normal limits. More studies are needed to determine if correcting lab abnormalities preoperatively can improve outcomes in patients with intrinsic coagulopathy.
No takes yet. Share an insight, caveat, or question.
Ball et al. (2019) conducted a cohort in Operative Subdural Hematomas (n=2,709). Preoperative platelet count < 135,000 vs. Preoperative platelet count > 135,000 was evaluated on 30-day mortality (OR 2.04, 95% CI 1.39-2.99, p=<0.001). Preoperative factors including platelet count < 135,000 (OR 2.04), INR > 1.2 (OR 1.87), and need for dialysis (OR 5.69) were significantly associated with increased 30-day mortality after surgical evacuation of subdural hematomas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: